Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Imatinib Plus Multi-Agent Chemotherapy for Newly Diagnosed Ph+ ALL
NCT00618501Phase 2Completed
- Sponsor
- Asan Medical Center
- Start
- Oct 2005
- Primary completion
- Dec 2008
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of imatinib in acute lymphoblastic leukemia (ALL), sponsored by Asan Medical Center. Started Oct 2005; status: completed.
02
Drugs
03
Conditions
acute lymphoblastic leukemia (ALL)
Beyond the preview
Go deeper on NCT00618501.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00618501.